Vivelle-Dot Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Vivelle-Dot
O
- Octocaine 100 (epinephrine / lidocaine)
- Ocudox (doxycycline)
- ofloxacin
- Ojemda (tovorafenib)
- Ojjaara (momelotinib)
- Okebo (doxycycline)
- Olumiant (baricitinib)
- olutasidenib
- omadacycline
- omaveloxolone
- ombitasvir / paritaprevir / ritonavir
- Omeclamox-Pak (amoxicillin / clarithromycin / omeprazole)
- Omnipen (ampicillin)
- Omnipen-N (ampicillin)
- Omnitrope (somatropin)
- Onglyza (saxagliptin)
- Onmel (itraconazole)
- Onsolis (fentanyl)
- Opzelura (ruxolitinib topical)
- Oracea (doxycycline)
- Orapred (prednisolone)
- Orapred ODT (prednisolone)
- Orasone (prednisone)
- Oravig (miconazole)
- Oraxyl (doxycycline)
- Orbactiv (oritavancin)
- Orbivan (acetaminophen / butalbital / caffeine)
- Orbivan CF (acetaminophen / butalbital)
- Oriahnn (elagolix / estradiol / norethindrone)
- Orilissa (elagolix)
- Orinase (tolbutamide)
- oritavancin
- Orkambi (ivacaftor / lumacaftor)
- Orladeyo (berotralstat)
- Oroxine (levothyroxine)
- Ortikos (budesonide)
- Oseni (alogliptin / pioglitazone)
- osilodrostat
- ospemifene
- Osphena (ospemifene)
- oxacillin
- Oxbryta (voxelotor)
- oxcarbazepine
- Oxtellar XR (oxcarbazepine)
- oxtriphylline
- oxytetracycline
- oxytetracycline / phenazopyridine / sulfamethizole
- Ozempic (semaglutide)
More about Vivelle-Dot (estradiol)
- Vivelle-Dot consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (37)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: estrogens
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.